CAN
EW icon

Cetera Advisor Networks’s Edwards Lifesciences EW Stock Holding History

Cetera Advisor Networks’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		$8.03M Buy
84,028
+18,227
+28% +$1.53M 0.04% 437
2023
Q4 		$5.02M Sell
65,801
-4,519
-6% -$314K 0.03% 574
2023
Q3 		$4.87M Buy
70,320
+5,006
+8% +$402K 0.03% 532
2023
Q2 		$6.16M Buy
65,314
+3,824
+6% +$332K 0.04% 416
2023
Q1 		$5.09M Buy
61,490
+3,963
+7% +$312K 0.04% 471
2022
Q4 		$4.29M Buy
57,527
+31,989
+125% +$2.47M 0.03% 505
2022
Q3 		$2.11M Buy
25,538
+950
+4% +$91.4K 0.03% 567
2022
Q2 		$2.34M Sell
24,588
-406
-2% -$42K 0.03% 532
2022
Q1 		$2.94M Sell
24,994
-2,828
-10% -$317K 0.04% 485
2021
Q4 		$3.6M Buy
27,822
+240
+0.9% +$28K 0.04% 400
2021
Q3 		$3.12M Buy
27,582
+1,347
+5% +$154K 0.04% 399
2021
Q2 		$2.72M Buy
26,235
+13,978
+114% +$1.32M 0.04% 437
2021
Q1 		$1.02M Buy
12,257
+537
+5% +$45.4K 0.02% 579
2020
Q4 		$1.07M Buy
11,720
+200
+2% +$16.6K 0.02% 519
2020
Q3 		$920K Sell
11,520
-3,634
-24% -$284K 0.02% 509
2020
Q2 		$1.05M Buy
15,154
+6,871
+83% +$488K 0.03% 458
2020
Q1 		$521K Buy
8,283
+2,334
+39% +$168K 0.02% 602
2019
Q4 		$464K Buy
5,949
+84
+1% +$6.56K 0.01% 773
2019
Q3 		$429K Buy
5,865
+6
+0.1% +$421 0.01% 757
2019
Q2 		$362K Buy
5,859
+819
+16% +$49.5K 0.01% 817
2019
Q1 		$323K Buy
5,040
+321
+7% +$18.3K 0.01% 839
2018
Q4 		$242K Buy
4,719
+171
+4% +$8.65K 0.01% 850
2018
Q3 		$263K Buy
4,548
+291
+7% +$14.2K 0.01% 918
2018
Q2 		$206K Sell
4,257
-159
-4% -$7.42K 0.01% 775
2018
Q1 		$206K Buy
+4,416
New +$192K 0.01% 800
2016
Q4 		– Sell
-8,256
Closed -$332K – 898
2016
Q3 		$332K Buy
+8,256
New +$311K 0.01% 724
2016
Q2 		– Sell
-7,278
Closed -$214K – 844
2016
Q1 		$214K Buy
+7,278
New +$201K 0.01% 731

Other funds holding EW

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Cetera Advisor Networks's EW Position: Q1 2024 in Review

Cetera Advisor Networks increased its Edwards Lifesciences (EW) stake by 28% in Q1 2024, buying an estimated $1.53M and bringing the position to 84,028 shares worth $8.03M. The position accounts for 0.04% of the portfolio, ranked #437.

Cetera Advisor Networks first reported a position in EW in Q1 2016 and has held it in 27 quarters since. 1,280 funds tracked by Wall St. Rank hold EW as of Q1 2024.

  • Cetera Advisor Networks held 84,028 shares of Edwards Lifesciences worth $8.03M as of Q1 2024.
  • Cetera Advisor Networks bought 18,227 Edwards Lifesciences shares in Q1 2024, an estimated $1.53M.
  • Edwards Lifesciences made up 0.04% of Cetera Advisor Networks's portfolio in Q1 2024, its #437 holding.
  • Cetera Advisor Networks first reported a position in Edwards Lifesciences in Q1 2016 and has held it in 27 quarters since.
  • 1,280 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2024.

Based on Cetera Advisor Networks's 13F filing for Q1 2024, filed 15 May 2024.